
Carve 6.25 Tablet
Marketer
Serwina Pharmaceuticals Private Limited
Salt Composition
Carvedilol (6.25mg)
Overview Carve 6.25 Tablet
Carvex 6.25mg tablets are prescribed for managing hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving blood flow to the heart. This, in turn, reduces the risk of myocardial infarction and cerebrovascular accident. Administer Carvex 6.25mg tablets with food, adhering strictly to your physician's prescribed dosage and regimen. Consistent use is crucial, even with symptom improvement or controlled blood pressure. Discontinuation requires prior medical consultation to avoid potential complications. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed by your doctor), are recommended to enhance treatment efficacy. Although generally well-tolerated, potential side effects may include vertigo, cephalalgia, dyspnea, and fatigue. Report persistent or troublesome adverse effects to your doctor immediately. Prior to commencing therapy, inform your physician of any pre-existing cardiac or renal conditions. Pregnant or lactating women should seek medical advice before using Carvex 6.25mg tablets.
Uses of Carve 6.25 Tablet
Managing elevated blood pressure | Addressing angina pectoris | Treating congestive heart failure
Major Benefits of Carve 6.25 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Remember to take Carve 6.25mg with food.
Common Side effects of Carve 6.25 Tablet:
- Decreased blood pressure
- Headache
- Fatigue
- Dizziness
- Breathlessness
How to use Carve 6.25 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Carve 6.25mg tablets should be taken with a meal.
How Carve 6.25 Tablet works:
Six point two five milligram Carve tablets combine alpha and beta-blocking properties. Their mechanism of action involves decelerating the heart rhythm and vasodilation, thereby improving the heart's pumping capacity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Carve 6.25 Tablet is not advisable.
PregnancyCONSULT YOUR DOCTOR
Using Carve 6.25 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on available evidence, the 6.25 mg Carve tablet appears to pose a negligible risk to breastfeeding infants. Limited studies in humans indicate minimal danger to the nursing child.
DrivingUNSAFE
Taking a 6.25 mg Carve tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Carve 6.25 Tablet poses no known safety risk for individuals with kidney impairment; dosage modification isn't typically necessary. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advised. Routine blood pressure checks are suggested to guide any potential dosage changes.
LiverCAUTION
Patients with liver impairment should use Carve 6.25 Tablet cautiously, potentially requiring dosage modification. Consult a physician before use. Carve 6.25 Tablet is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Carve 6.25 Tablet :
Should you forget a Carve 6.25 Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing schedule. Avoid taking a double dose.
Facts to Know About Carve 6.25 Tablet
| Label | Value |
|---|---|
| Chemical Type | Carbazole-propanol derivative |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Actions | Alpha-beta blocker |
